These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 1694159

  • 21. Intercellular adhesion molecule-1 in proliferative vitreoretinopathy.
    Limb GA, Chignell AH, Cole CJ, Green WT, Webster L, Hollifield RD, Dumonde DC.
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1043-8. PubMed ID: 9113001
    [Abstract] [Full Text] [Related]

  • 22. [Thrombospondin and its importance in proliferative retinal diseases].
    Esser P, Weller M, Heimann K, Wiedemann P.
    Fortschr Ophthalmol; 1991 Apr; 88(4):337-40. PubMed ID: 1786916
    [Abstract] [Full Text] [Related]

  • 23. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study.
    Kon CH, Occleston NL, Aylward GW, Khaw PT.
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):705-12. PubMed ID: 10067974
    [Abstract] [Full Text] [Related]

  • 24. Class II histocompatibility antigen expression by cellular components of vitreous and subretinal fluid in proliferative vitreoretinopathy.
    Baudouin C, Brignole F, Bayle J, Fredj-Reygrobellet D, Lapalus P, Gastaud P.
    Invest Ophthalmol Vis Sci; 1991 Jun; 32(7):2065-72. PubMed ID: 2055699
    [Abstract] [Full Text] [Related]

  • 25. [Protein composition of the vitreous body in proliferative diabetic retinopathy. An analysis with 2-D-electrophoresis].
    Bresgen M, Baum U, Esser P, Wiedemann P, Heimann K.
    Ophthalmologe; 1994 Dec; 91(6):758-62. PubMed ID: 7849428
    [Abstract] [Full Text] [Related]

  • 26. [Lactoferrin and transferrin--iron-binding proteins in physiological and pathological vitreous bodies].
    Moter H, Weller M, Heimann K, Wiedemann P.
    Fortschr Ophthalmol; 1990 Dec; 87(4):336-9. PubMed ID: 2210558
    [Abstract] [Full Text] [Related]

  • 27. Regulation of integrin-mediated adhesion at focal contacts by cyclic AMP.
    Glass WF, Kreisberg JI.
    J Cell Physiol; 1993 Nov; 157(2):296-306. PubMed ID: 7693723
    [Abstract] [Full Text] [Related]

  • 28. Vitronectin in atherosclerotic disease.
    Ekmekçi OB, Ekmekçi H.
    Clin Chim Acta; 2006 Jun; 368(1-2):77-83. PubMed ID: 16460719
    [Abstract] [Full Text] [Related]

  • 29. The chemoattractant activity of the vitreous to human scleral fibroblasts following retinal detachment and proliferative vitreoretinopathy.
    Wilson-Holt N, Khaw P, Savage F, Grierson I.
    Br J Ophthalmol; 1992 Mar; 76(3):159-62. PubMed ID: 1540560
    [Abstract] [Full Text] [Related]

  • 30. Vitronectin and proliferative intraocular disorders. II. Expression of cell surface receptors for fibronectin and vitronectin in periretinal membranes.
    Weller M, Wiedemann P, Bresgen M, Heimann K.
    Int Ophthalmol; 1991 Mar; 15(2):103-8. PubMed ID: 1708746
    [Abstract] [Full Text] [Related]

  • 31. Mononuclear phagocytes in proliferative vitreoretinopathy (PVR). A specific role of microglial cells in non-traumatic disease?
    Weller M, Esser P, Heimann K, Wiedemann P.
    Eur J Ophthalmol; 1991 Mar; 1(4):161-6. PubMed ID: 1821209
    [Abstract] [Full Text] [Related]

  • 32. The significance of fibronectin in vitreoretinal pathology. A critical evaluation.
    Weller M, Wiedemann P, Heimann K, Zilles K.
    Graefes Arch Clin Exp Ophthalmol; 1988 Mar; 226(3):294-8. PubMed ID: 3402754
    [Abstract] [Full Text] [Related]

  • 33. Immunoglobulin G, complement factor C3 and lymphocytes in proliferative intraocular disorders.
    Weller M, Clausen R, Bresgen M, Heimann K, Wiedemann P.
    Int Ophthalmol; 1990 Jul; 14(4):277-83. PubMed ID: 2196238
    [Abstract] [Full Text] [Related]

  • 34. [Physiopathology of the vitreous body].
    Stankiewicz A.
    Klin Oczna; 1976 Jun; 46(6):677-85. PubMed ID: 966629
    [No Abstract] [Full Text] [Related]

  • 35. Fibronectin quantification in plasma and vitreous by a noncompetitive ELISA technique.
    Weller M, Wiedemann P, Heimann K, Zilles K.
    Doc Ophthalmol; 1988 Aug; 69(4):341-51. PubMed ID: 3203602
    [Abstract] [Full Text] [Related]

  • 36. Metalloproteinases and TIMP-1 in proliferative vitreoretinopathy.
    Limb AS, Miller K, Chignell AH, Williamson TH, Hollifield RD, Dumonde DC.
    Biochem Soc Trans; 1997 May; 25(2):234S. PubMed ID: 9191278
    [No Abstract] [Full Text] [Related]

  • 37. Vitronectin: effects on keratinocyte motility and inhibition of collagen-induced motility.
    Brown C, Stenn KS, Falk RJ, Woodley DT, O'Keefe EJ.
    J Invest Dermatol; 1991 May; 96(5):724-8. PubMed ID: 1708798
    [Abstract] [Full Text] [Related]

  • 38. Physicochemical, immunochemical and functional comparison of human S-protein and vitronectin. Evidence for the identity of both plasma proteins.
    Preissner KT, Heimburger N, Anders E, Müller-Berghaus G.
    Biochem Biophys Res Commun; 1986 Jan 29; 134(2):951-6. PubMed ID: 2418831
    [Abstract] [Full Text] [Related]

  • 39. The role of vitronectin as multifunctional regulator in the hemostatic and immune systems.
    Preissner KT.
    Blut; 1989 Nov 29; 59(5):419-31. PubMed ID: 2479432
    [Abstract] [Full Text] [Related]

  • 40. On the identity of vitronectin and S-protein: immunological crossreactivity and functional studies.
    Tomasini BR, Mosher DF.
    Blood; 1986 Sep 29; 68(3):737-42. PubMed ID: 2427139
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.